Our mission is to become a worldwide reference for education in the field for all professionals involved in the process to disseminate knowledge & skills of Acute Cardiovascular Care.
Our mission is to promote excellence in clinical diagnosis, research, technical development, and education in cardiovascular imaging.
Our mission is to promote excellence in research, practice, education and policy in cardiovascular health, primary and secondary prevention.
Our mission is to reduce the burden of cardiovascular disease through percutaneous cardiovascular interventions.
Improving the quality of life and reducing sudden cardiac death by limiting the impact of heart rhythm disturbances.
Our mission is to improve quality of life and longevity, through better prevention, diagnosis and treatment of heart failure, including the establishment of networks for its management, education and research.
The ESC Working Groups' goal is to stimulate and disseminate scientific knowledge in different fields of cardiology.
The ESC Councils' goal is to share knowledge among medical professionals practicing in specific cardiology domains.
China, People's Republic of, CN
president: Prof. Junbo Ge,
President: Prof Junbo GE, FESC
President Elect: Prof Yaling HAN, FESC
Prof Jian'an WANG, FESC
Prof Yun ZHANG, FESC
Dr Bo YU, FESC
General Secretary: Prof Yundai CHEN
Deputy General Secretary:
Dr Jiyan CHEN
Dr Juying QIAN
Past-President: Dr Yong HUO, FESC
Number of members: tbc
Year of foundation: 1978
Year of ESC affiliation: 2010
19th Annual Scientific Congress of the Chinese Society of Cardiology14-17 September 2017Taiyuan, Shangxi province, China
The Chinese Society of Cardiology (CSC) was founded in August 1978 in Taiyuan, and the board members were elected. Besides Wu Yingkai, the President, and Tao Shouqi, Huang Yuan, Fang Qi and Shi Meixin as the Vice-Presidents, there were in total 59 committee members in China (except Taiwan). Since then, local branches of CSC have been founded in many provinces all over China.After more than 30 years development, CSC has become the most recognised cardiovascular association in China. The association has had eight different boards since its creation and each time the new board members made developments and improvements in both scientifically and organisationally in order to keep the society along with the pace of time. The details of developments and improvements are s follows:With the first board after the society was founded, the society focused mainly on the foundation of regional branches in the provinces of China, and a network was created in order to facilitate the regional cooperation. At that time, many scientific activities were held in the larger regional areas. The first board of directors also launched the official journal of the society, Chinese Journal of Cardiology, which has now become the most recognised cardiovascular publication in China. Second board of directors was elected at the annual meeting in 1983, during which 122 professional papers were selected and presented. The editorial board of the Chinese Journal of Cardiology was also re-elected same year. Many conferences were held, such as the national conference of hypertension in 1985, the national conference of coronary heart disease in 1986 and the national conference of cardiovascular disease prevention and treatment. During the third and fourth boards the society saw the creation of four new scientific committees. In 1989 the society became a member of the World Hypertension League and the Chinese Hypertension League was formed the same year. The national clinical research of acute myocardial infarction was also organised in 1989, with more than 500 participants and 10 000 clinical observations included. On the basis of this, the society published the book Clinical Hypertension, which won the award as the best national technology book. National development training courses in cardiovascular disease was held in 1991, 1992 and 1993. The fifth board was composed of a total of 39 members and 9 youth committee members. Six additional scientific committees were formed and the society held the sixth national conference in Shanghai in 2000 with over 1500 participants. This conference provided a platform for the communication of the latest progress, also in the area of prevention in CV, facilitating the development of the diagnoses and treatment of cardiovascular disease in China. The society launched a large scale survey on auricular fibrillation and heart failure, leading to the creation of five guidelines on unstable angina pectoris, acute myocardial infarction, heart failure, arrhythmic drugs, and diagnostic criteria in adult acute viral myocarditis. The sixth and seventh board counted 41 board members and six additional new scientific committees were set up. The number attendees to the seminars have since been over 1500. The CIT (China Interventional Therapeutics) congress eased the development of Chinese interventional cardiology and scientific communication and thus enlarged the society’s influence on the international scientific scene. In June 2009 the national conference of cardiovascular disease was held in Dalian and the current and eighth board was elected. 10 scientific committees were set up at the occasion of this conference. Under the lead of the current board members the society will focus on practical work and scientific activities. More professional papers will be organised for the annual meeting in order to develop more scientific communication. One of the major achievements has so far been the involvement in the WCC congress in Beijing which earned much attention and reflection in Taiwan, Hong Kong and Singapore and was a very influential cardiology congress.
The Chinese Journal of Cardiology (ISSN 0253-3758 / CN 11-2148/R) is the official journal of the CSC and was first published in February 1973. The current editorial board is composed of renowned cardiovascular experts including Dr Gao RUNLIN as the editor in chief. Target readers are doctors in cardiovascular disease prevention, medicine and scientific research and the journal occupies the biggest reader group and circulation of all professional cardiovascular journals in China. It has thus been recommended by many international organisation and included by MEDLINE, BIOSIS, AJ, VINITI, BA, TOXCENTER, CJFD, CBM and the Chinese Academic Journals comprehensive Citation Report. Chinese Journal of Cardiology was changed from quarterly to bimonthly journal in 1987.
Chinese Society of Cardiology
Room 412, Science & Education Building
People's Hospital, No 11 Xi Zhi Men S. Ave.,
100044Beijing, China, People's Republic of
Tel. +86 10 8980 7029
Our mission: To reduce the burden of cardiovascular disease
© 2017 European Society of Cardiology. All rights reserved